We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZM icon
3151
Zoom
ZM
$31B
$48.6K ﹤0.01%
676
-2,039
-75% -$135K
LE icon
3152
Lands' End
LE
$376M
$48.6K ﹤0.01%
5,081
+3,912
+335% +$29.1K
NECB icon
3153
Northeast Community Bancorp
NECB
$373M
$48.5K ﹤0.01%
2,733
+1,315
+93% +$21.4K
GRWG icon
3154
GrowGeneration
GRWG
$104M
$48.4K ﹤0.01%
19,282
+2,197
+13% +$5.38K
FMS icon
3155
Fresenius Medical Care
FMS
$12.6B
$48.2K ﹤0.01%
2,314
+1,799
+349% +$34.5K
BRLT icon
3156
Brilliant Earth
BRLT
$22.3M
$48.1K ﹤0.01%
12,924
-22,515
-64% -$64.8K
VPG icon
3157
Vishay Precision Group
VPG
$952M
$48K ﹤0.01%
1,410
-1,193
-46% -$37.4K
RCUS icon
3158
Arcus Biosciences
RCUS
$3.69B
$48K ﹤0.01%
2,514
-2,270
-47% -$36.3K
PRTS icon
3159
CarParts.com
PRTS
$49.4M
$47.9K ﹤0.01%
1,515
+1,200
+381% +$40.5K
VTGN icon
3160
VistaGen Therapeutics
VTGN
$11.8M
$47.8K ﹤0.01%
+9,298
New +$35.2K
EBS icon
3161
Emergent Biosolutions
EBS
$237M
$47.7K ﹤0.01%
19,867
+6,823
+52% +$16K
SMC
3162
Summit Midstream
SMC
$477M
$47.6K ﹤0.01%
+2,660
New +$49.7K
REYN icon
3163
Reynolds Consumer Products
REYN
$5.52B
$47.5K ﹤0.01%
1,770
-3,699
-68% -$96.6K
SFL icon
3164
SFL Corp
SFL
$1.65B
$47.3K ﹤0.01%
4,194
+513
+14% +$5.71K
PETS icon
3165
PetMed Express
PETS
$39.8M
$47.2K ﹤0.01%
6,246
+1,525
+32% +$12.5K
TH icon
3166
Target Hospitality
TH
$1.73B
$47.2K ﹤0.01%
4,849
+4,215
+665% +$52.1K
AUGX
3167
DELISTED
Augmedix, Inc. Common Stock
AUGX
$47.2K ﹤0.01%
8,062
-28,766
-78% -$151K
IBRX icon
3168
ImmunityBio
IBRX
$7.94B
$47.2K ﹤0.01%
9,393
+2,844
+43% +$8.92K
FNGR icon
3169
FingerMotion
FNGR
$18.8M
$47.1K ﹤0.01%
11,724
+11,158
+1,971% +$55.2K
JPEF icon
3170
JPMorgan Equity Focus ETF
JPEF
$2.07B
$46.9K ﹤0.01%
890
-10,539
-92% -$521K
NBP
3171
NovaBridge Biosciences American Depositary Shares
NBP
$226M
$46.8K ﹤0.01%
24,608
-3,510
-12% -$5.24K
SNDL icon
3172
Sundial Growers
SNDL
$313M
$46.8K ﹤0.01%
28,507
+17,669
+163% +$26.6K
XENE icon
3173
Xenon Pharmaceuticals
XENE
$6B
$46.7K ﹤0.01%
1,014
+817
+415% +$28.9K
ASAI
3174
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
$46.7K ﹤0.01%
3,378
+2,846
+535% +$35.5K
NXDR
3175
Nextdoor Holdings
NXDR
$1B
$46.7K ﹤0.01%
24,688
+17,950
+266% +$31.7K

Similar funds

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.